Search
CELL BANK Website

Back Back
Cell No. : Cell Name
RCB2534 : M-MOK  update : 2024/01/17
CommentHuman cell line derived from megakaryoblastic leukemia. TKG0458 (Deposited from Tohoku Univ.).
Comment from the depositor
Terms and conditionsThere is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Remarks
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Basic information Depositor Fukuda, Hiroshi
Originator Itano, Masataka
Year of deposit 2007
Original cell TKG0458
Animal _human < Mammals
Genus Homo
Species sapiens
Gender Female
Tissue bone marrow
Disease name immature megakaryoblastic leukemia
Classification cancer
History Cell Resource Center for Biomedical Research, Tohoku University(TKG0458)
Lifespan infinite
Morphology lymphoblast-like
Cellosaurus(Expasy) CVCL_8731
deposit info
lot info
Medium Medium List
Culture type Suspension cells
Culture medium RPMI1640 + 10% FBS + 10ng/ml GM-CSF
Culture method
Antibiotics Free
Passage method dilution
Culture information Passage ratio 1 : 10 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
Virus (HIV) LT 400
Virus (HTLV-1) (-)
Isozyme LD, NP
STR(human) OK
Images
deposit info
lot info
Reference information Reference 2
User's Publication 2


To topTop
Reference
5195  Morita S1, Tsuchiya S, Fujie H, Itano M, Ohashi Y, Minegishi M, Konno T.  Isolation and characterization of two monoclonal antibodies that recognize different epitopes of the human c-kit receptor.  Tohoku J Exp Med  1996  178(2):187-98  PubMed ID: 8727700   DOI: 10.1620/tjem.178.187
5194  Itano M, Tsuchiya S, Minegishi N, Fujie H, Minegishi M, Morita S, Yambe T, Ohashi Y, Masuda T, Koike T, et al.  Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability.  Exp Hematol  1995  23(12):1301-9  PubMed ID: 7589286  

To topTop
User's Publication
21650  Matsuo H, Inagami A, Ito Y, Ito N, Iyoda S, Harata Y, Higashitani M, Shoji K, Tanaka M, Noura M, Mikami T, Kato I, Takita J, Nakahata T, Adachi S.  Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes.  Commun Biol  2024  7(1):123  PubMed ID: 38267545   DOI: 10.1038/s42003-024-05811-8
11559  Drenberg CD, Shelat A, Dang J, Cotton A, Orwick SJ, Li M, Jeon JY, Fu Q, Buelow DR, Pioso M, Hu S, Inaba H, Ribeiro RC, Rubnitz JE, Gruber TA, Guy RK, Baker SD.  A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.  Nat Commun  2019    PubMed ID: 31097698   DOI: 10.1038/s41467-019-09917-0



Back Back Return Top Page